Skip Navigation


Human Molecular Genetics Advance Access originally published online on June 22, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
13/16/1793    most recent
ddh189v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (38)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Schubert, R.
Right arrow Articles by Wynshaw-Boris, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schubert, R.
Right arrow Articles by Wynshaw-Boris, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2004, Vol. 13, No. 16 1793-1802
DOI: 10.1093/hmg/ddh189
Human Molecular Genetics, Vol. 13, No. 16 © Oxford University Press 2004; all rights reserved

Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice

Ralf Schubert1,2,3,{dagger}, Laura Erker1,2,3,{dagger}, Carrolee Barlow4,{ddagger}, Hiroyuki Yakushiji1,2,3, Denise Larson4, Angelo Russo5, James B. Mitchell5 and Anthony Wynshaw-Boris1,2,3,4,*

1Department of Pediatrics, 2Department of Medicine and 3The Comprehensive Cancer Center, UCSD School of Medicine, La Jolla, CA, USA, 4Genetic Disease Research Branch, NHGRI and 5Radiation Biology Branch, NCI, Bethesda, MD, USA

Received April 28, 2004; Accepted June 11, 2004

Reactive oxygen species (ROS) are important endogenous etiological agents for DNA damage, and ROS perform critical signaling functions in apoptosis, stress responses and proliferation. The correlation between a lower incidence of cancer in people who consume a diet high in naturally occurring antioxidants and the observed increased ROS in cancerous tissues suggest that antioxidants may be used in cancer chemoprevention. We tested this hypothesis by determining whether the well-described nitroxide antioxidant, tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl), acts as a chemopreventative agent in Atm mutant mice, a model of the human cancer prone syndrome ataxia-telangiectasia. Tempol administered continuously via the diet after weaning resulted in an increased lifespan of these mice by prolonging the latency to thymic lymphomas. Tempol treatment reduced ROS, restored mitochondrial membrane potential, reduced tissue oxidative damage and oxidative stress, consistent with antioxidant effects. In addition, this nitroxide lowered weight gain of tumor prone mice without changes in food intake, metabolism or activity level and exhibited an anti-proliferative effect in vitro. Thus, tempol acts as a novel chemopreventative agent in this mouse model of a human cancer prone syndrome, associated with broad antioxidant effects.

* To whom correspondence should be addressed at: School of Medicine, University of California, San Diego, 9500 Gilman Drive, Mail Stop 0627, La Jolla, CA, 92093-0627, USA. Tel: +1 8588223400; Fax: +1 8588223409; Email: awynshawboris{at}ucsd.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. C. Ghosh, W.-H. Tong, D. Zhang, H. Ollivierre-Wilson, A. Singh, M. C. Krishna, J. B. Mitchell, and T. A. Rouault
Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice
PNAS, August 19, 2008; 105(33): 12028 - 12033.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Zha, J. Sekiguchi, J. W. Brush, C. H. Bassing, and F. W. Alt
Complementary functions of ATM and H2AX in development and suppression of genomic instability
PNAS, July 8, 2008; 105(27): 9302 - 9306.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Q.-S. Zhang, L. Eaton, E. R. Snyder, S. Houghtaling, J. B. Mitchell, M. Finegold, C. Van Waes, and M. Grompe
Tempol Protects against Oxidative Damage and Delays Epithelial Tumor Onset in Fanconi Anemia Mice
Cancer Res., March 1, 2008; 68(5): 1601 - 1608.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. Ambrose, J. V. Goldstine, and R. A. Gatti
Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells
Hum. Mol. Genet., September 15, 2007; 16(18): 2154 - 2164.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Bagley, G. Singh, and J. Iacomini
Regulation of Oxidative Stress Responses by Ataxia-Telangiectasia Mutated Is Required for T Cell Proliferation
J. Immunol., April 15, 2007; 178(8): 4757 - 4763.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Ito, K. Takubo, F. Arai, H. Satoh, S. Matsuoka, M. Ohmura, K. Naka, M. Azuma, K. Miyamoto, K. Hosokawa, et al.
Regulation of Reactive Oxygen Species by Atm Is Essential for Proper Response to DNA Double-Strand Breaks in Lymphocytes
J. Immunol., January 1, 2007; 178(1): 103 - 110.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. Reliene and R. H. Schiestl
Antioxidants Suppress Lymphoma and Increase Longevity in Atm-Deficient Mice
J. Nutr., January 1, 2007; 137(1): 229S - 232S.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. G. Havens, A. Ho, N. Yoshioka, and S. F. Dowdy
Regulation of Late G1/S Phase Transition and APCCdh1 by Reactive Oxygen Species
Mol. Cell. Biol., June 15, 2006; 26(12): 4701 - 4711.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. Rasheed, X. Wang, Q.-T. Niu, J. Yeh, and B. Li
Atm-deficient mice: an osteoporosis model with defective osteoblast differentiation and increased osteoclastogenesis
Hum. Mol. Genet., June 15, 2006; 15(12): 1938 - 1948.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Lu, K. C. Shen, Y. Wang, S.C. Brooks, and Y. A. Wang
Impaired hepatocyte survival and liver regeneration in Atm-deficient mice
Hum. Mol. Genet., October 15, 2005; 14(20): 3019 - 3025.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. P. Cotrim, A. L. Sowers, B. M. Lodde, J. M. Vitolo, A. Kingman, A. Russo, J. B. Mitchell, and B. J. Baum
Kinetics of Tempol for Prevention of Xerostomia Following Head and Neck Irradiation in a Mouse Model
Clin. Cancer Res., October 15, 2005; 11(20): 7564 - 7568.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L. Erker, R. Schubert, H. Yakushiji, C. Barlow, D. Larson, J. B. Mitchell, and A. Wynshaw-Boris
Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor
Hum. Mol. Genet., June 15, 2005; 14(12): 1699 - 1708.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.